August 22, 2018

Our new work on systems biology of lung cancer has proposed a precision oncology platform for treatment pf NSCLC by allupurinol and a JAK2 inhibitor based on gene signatures.

This work is now available on bioRxiv. 

Please reload

Featured Posts

Biology Journal

May 11, 2020

1/5
Please reload

Recent Posts

May 11, 2020

May 10, 2020

Please reload

Archive
Please reload

Search By Tags